M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 131,764 shares, an increase of 304.4% from the February 12th total of 32,579 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 24,712 shares, the short-interest ratio is presently 5.3 days. Based on an average daily volume of 24,712 shares, the short-interest ratio is presently 5.3 days. Currently, 0.4% of the company’s stock are short sold.
M3-Brigade Acquisition V Stock Performance
Shares of NASDAQ MBAV traded up $0.02 during midday trading on Thursday, hitting $10.73. 5,223 shares of the company’s stock were exchanged, compared to its average volume of 124,737. M3-Brigade Acquisition V has a 12 month low of $10.19 and a 12 month high of $13.73. The company’s 50 day moving average price is $10.67 and its 200 day moving average price is $10.62.
Insider Transactions at M3-Brigade Acquisition V
In other news, major shareholder Fitzgerald & Co. Cantor bought 3,529,081 shares of the stock in a transaction on Wednesday, December 17th. The stock was purchased at an average price of $10.80 per share, for a total transaction of $38,114,074.80. Following the acquisition, the insider owned 7,779,865 shares in the company, valued at approximately $84,022,542. This trade represents a 83.02% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Hedge Funds Weigh In On M3-Brigade Acquisition V
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.
Get Our Latest Research Report on MBAV
About M3-Brigade Acquisition V
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
See Also
- Five stocks we like better than M3-Brigade Acquisition V
- Gold’s Big Move May Be Creating Early Opportunities
- The largest IPO in history is coming
- The greatest wealth transfer of our lifetime has started
- Elon Musk’s $1 Quadrillion AI IPO
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
